Watch the Spot试验中CT相关辐射剂量:小肺结节积极随访中低强度与高强度策略的实用随机试验
Watch the Spot是一项整群随机实用临床试验,比较小肺结节低强度与高强度随访策略。研究纳入美国24个中心34,686例患者(2017年3月至2019年7月),21个中心提供剂量数据。结果显示两研究组两年累积随访剂量相似(18.6 vs 19.0 mSv,P=.90),但筛查和随访CT的体型校正剂量在中心内及中心间差异很大,且常超过ACR/AAPM推荐阈值。
要点
- 筛查CT平均体型校正CTDIvol范围1.6–8.0 mGy,随访CT为4.0–14 mGy,中心间差异显著。
- 44%筛查和61%随访CT超过ACR/AAPM CTDIvol阈值,81%和88%超过DLP阈值。
- 低强度与高强度随访组两年累积随访剂量相似(18.6 vs 19.0 mSv,P=.90)。
核心结论
- 低强度与高强度随访组两年累积辐射剂量相似,但筛查和随访CT的体型校正剂量在中心内及中心间差异广泛,且频繁超过推荐阈值。
研究设计与样本
- 整群随机实用临床试验,纳入美国24个中心34,686例小肺结节患者(2017年3月至2019年7月),剂量估计来自21个中心,累积随访剂量来自22个中心,参考标准为ACR/AAPM剂量阈值。
诊断标准与关键数值
- 筛查CT平均体型校正CTDIvol范围1.6 mGy(SD=0.43)至8.0 mGy(SD=2.5),DLP范围62 mGy-cm(SD=16)至301 mGy-cm(SD=102),有效剂量范围1.7 mSv(SD=0.46)至11 mSv(SD=3.7)。
- 随访CT平均剂量更高且变异更大:CTDIvol范围4.0 mGy(SD=3.5)至14 mGy(SD=9.8),DLP范围157 mGy-cm(SD=143)至443 mGy-cm(SD=395),有效剂量范围5.1 mSv(SD=5.4)至16 mSv(SD=14)。
- 44%的筛查CT和61%的随访CT超过ACR/AAPM CTDIvol阈值,81%和88%分别超过DLP阈值。
- 两年累积随访成像剂量(排除基线扫描)低强度组18.6 mSv vs 高强度组19.0 mSv,P=.90。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Watch the Spot is a cluster-randomized pragmatic clinical trial comparing less versus more intensive surveillance strategies for small pulmonary nodules. This article describes radiation doses from screening and follow-up imaging.
METHODS: In all, 34,686 patients with small nodules were enrolled across 24 US sites (March 2017 to July 2019). Dose estimates were available from 21 sites and reported as size-adjusted CT dose index-volume (CTDIvol), dose-length product (DLP), and effective dose standardized to an 80-kg patient. Mean (SD) doses for screening and follow-up CTs and the proportion exceeding ACR/AAPM dose thresholds were calculated. Two-year cumulative follow-up imaging doses (excluding baseline scans) were estimated from 22 sites and compared between study arms.
RESULTS: Radiation doses varied substantially across sites. For screening, mean size-adjusted CTDIvol ranged from 1.6 mGy (SD = 0.43) to 8.0 mGy (SD = 2.5), DLP from 62 mGy-cm (SD = 16) to 301 mGy-cm (SD = 102), and effective dose from 1.7 mSv (SD = 0.46) to 11 mSv (SD = 3.7). Follow-up scans had higher mean doses and wider variation: CTDIvol ranged from 4.0 mGy (SD = 3.5) to 14 mGy (SD = 9.8), DLP from 157 mGy-cm (SD = 143) to 443 mGy-cm (SD = 395), and effective dose from 5.1 mSv (SD = 5.4) to 16 mSv (SD = 14). Overall, 44% of screening and 61% of follow-up scans exceeded ACR/AAPM CTDIvol thresholds, and 81% and 88% exceeded DLP thresholds. Cumulative follow-up doses were similar between study arms (18.6 versus 19.0 mSv, P = .90).
CONCLUSION: Two-year cumulative radiation dose was similar for patients in the less and more intensive surveillance arms; however, patient size-adjusted doses both for screening and follow-up CTs varied widely within and across sites and frequently exceeded recommended thresholds.
引用
- Smith-Bindman R, Miglioretti DL, Li Y, et al. Radiation Dose Associated With CT in the Watch the Spot Trial: A Pragmatic Trial of Less Versus More Intensive Strategies for Active Follow-Up of Patients With Small Pulmonary Nodules. J Am Coll Radiol. 2025. PMID: 41338712. doi:10.1016/j.jacr.2025.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。